Business Wire

ISACA Expands European Presence With New Office in Dublin

9.9.2022 15:30:00 EEST | Business Wire | Press release

Share

As a result of the continued growth and development over the last 50 years, ISACA, the global professional association advancing individuals and organizations in their pursuit of digital trust, is expanding its international reach and opening a new office in Dublin—its first European office.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220909005075/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Chris Dimitriadis, Chief Global Strategy Officer at ISACA (Photo: Business Wire)

ISACA´s success is defined by the passion, hard work and commitment of its more than 165,000 members in more than 180 countries worldwide. In Europe, the organization has over 30,000 members working in information and cyber security, assurance, governance, risk and privacy from different industries such as Banking & Finance, Government, Telecommunications, Engineering, Public Accounting, Education, Retail, Health, FMCG, Automotive, Utilities, Food & Beverage among others.

ISACA in Europe combines the strength and scale of a large, multi-national organization with an expert, local knowledge of the market and professional communities ISACA serves. The new office intends to facilitate cooperation between European regions, chapters and members and strengthen ISACA’s capacity to collaborate with key public and private stakeholders, as well as enterprises and academia.

“Our expanded regional presence in Europe will provide services dedicated to Europe and help extend our global reach and impact,” said ISACA CEO David Samuelson. “ISACA is both a global and a local organization, and we want to serve our professional communities where they live and work. We are very excited to have a stronger local presence in Europe to better partner with European government, enterprises, universities and our members to advance digital trust.”

The office and ISACA’s new team members in Europe will build on the strong ties that already exist between regions by promoting investment, synergies and economic opportunities to benefit members and enterprises.

Ireland’s Minister of State for eGovernment Ossian Smyth said, “We welcome ISACA’s commitment and investment into Ireland. As we continue to develop Ireland as a European hub for the digital economy and as a cyber centre of excellence, it is crucial to continue to build an expert and diverse specialist ecosystem. ISACA’s pre-eminent global work on talent development, building the cyber profession and developing tools and frameworks to underpin the next phase of technology adoption in a safe and transparent manner, will be a boost to our tech scene. We look forward to ongoing cooperation with ISACA in improving cybersecurity preparedness and resilience.”

ISACA’s European presence is led by Chris Dimitriadis, Chief Global Strategy Officer at ISACA. Dimitriadis has deep industry and ISACA experience, having served as ISACA board chair and as a past chief information security officer at a global organization.

“ISACA has a long history in Europe, and we are incredibly proud of our chapters, volunteers, members and partners in the region,” said Dimitriadis. “We are excited to strengthen our support in the communities that we serve by establishing a team of highly experienced and reputable European professionals and by opening our first office in Dublin that will strategically coordinate and support our 45 chapters in Europe and our business, government and academic partners.”

ISACA, established in 1969, is widely known for its globally recognized certifications, including Certified Information Systems Auditor (CISA) and Certified Information Security Manager (CISM), and its industry-leading frameworks, including COBIT. Additional information is at www.isaca.org/.

About ISACA

ISACA® (www.isaca.org) is a global community advancing individuals and organizations in their pursuit of digital trust. For more than 50 years, ISACA has equipped individuals and enterprises with the knowledge, credentials, education, training and community to progress their careers, transform their organizations, and build a more trusted and ethical digital world. ISACA is a global professional association and learning organization that leverages the expertise of its more than 165,000 members who work in digital trust fields such as information security, governance, assurance, risk, privacy and quality. It has a presence in 188 countries, including 225 chapters worldwide. Through its foundation One In Tech, ISACA supports IT education and career pathways for underresourced and underrepresented populations.

Twitter: www.twitter.com/ISACANews
LinkedIn: www.linkedin.com/company/isaca
Facebook: www.facebook.com/ISACAGlobal
Instagram: www.instagram.com/isacanews

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Esther Almendros, ealmendros@isaca.org, T: +1 847-660-5777, M: +34 692 669 722

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye